The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells
Open Access
- 22 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (1) , 101443
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
This publication has 19 references indexed in Scilit:
- The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer CellsCell Reports, 2013
- GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1αBlood, 2012
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Characteristics of triple-negative breast cancerJournal of Cancer Research and Clinical Oncology, 2010
- Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer‐predisposing geneMolecular Oncology, 2008
- Development of therapeutic approaches to ‘triple negative’ phenotype breast cancerExpert Opinion on Therapeutic Targets, 2008
- Triple negative tumours: a critical reviewHistopathology, 2007
- The ubiquitin-specific protease USP28 is required for MYC stabilityNature Cell Biology, 2007
- A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage ResponseCell, 2006
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004